TENOLIEVA 300 MG Tenofovir Disoproxil fumarate Viread

Tenolieva 300 mg Tablets
Composition: Tenofovir Disoproxil Fumarate 300 mg
International Trade Name: Viread®

Tenolieva 300 mg Tablets is a high-quality Tenofovir Disoproxil Fumarate (TDF) 300 mg oral tablet, a trusted antiviral therapy equivalent to the internationally recognized brand Viread®. Manufactured in WHO-GMP certified facilities, Tenolieva Tablets are supplied by reputable pharmaceutical exporters from India, supporting global HIV and chronic hepatitis B virus (HBV) treatment programs.

Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI) that effectively suppresses viral replication in HIV-1 and HBV infections, helping maintain immune function and preventing disease progression. Tenolieva 300 mg Tablets are primarily indicated for the treatment of adult and adolescent patients with HIV-1 infection and chronic hepatitis B infection.

Keywords: Tenofovir Disoproxil Fumarate 300 mg tablet, Tenolieva tablet, Viread biosimilar, antiviral therapy, HIV treatment, chronic hepatitis B management, nucleotide reverse transcriptase inhibitor, pharmaceutical exporter India, antiviral tablet manufacturer India.

Tenolieva 300 mg Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, HIV treatment centers, government health programs, and international pharmaceutical distributors.